Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial) [Phase 3]
Phase 3 study of brentuximab vedotin in high-risk residual Hodgkin lymphoma after stem cell transplant completed with results posted.
-
CLINICAL_TRIALS trial_result · 2015-11-09Clinical Trial Update: Temsirolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of the combination temsirolimus and brentuximab vedotin in adults with relapsed…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease [Phase 2]
A Phase II study of MDX-060 in patients with relapsed or refractory Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease [NA]
Clinical trial update for Rituxan with BEAM and autologous stem cell transplant in high-risk lymphoma or Hodgkin's disease; trial completed …
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit [Phase 2]
Phase 2 clinical trial evaluating hematopoietic stem cell transplantation using a CD34-selected mismatched related donor plus one umbilical …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 1]
Phase 1 study of Vinorelbine Liposome Injection for advanced solid tumors, Hodgkin lymphoma, and Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 pilot trial evaluating radiation-enhanced allogeneic cell therapy for progressive hematologic malignancies after allogeneic stem cel…
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without radiation therapy in Hodgkin's lymphoma; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma [Phase 3]
This Phase 3 trial comparing ABVD versus BEACOPP regimens in advanced Hodgkin lymphoma has completed. The update notes the study status as c…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic maligna…
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial investigates the combination of lenalidomide with bendamustine in adults with relapsed or primary refractory Hodg…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms [Phase 1]
Termination of a Phase 1 trial evaluating oral azacitidine (CC-486) in Japanese subjects with hematological neoplasms.
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [Phase 3]
A Phase 3 trial investigating treatment for graft-versus-host disease in patients with recurrent or refractory lymphoma or Hodgkin's disease…
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy [Phase 2, Phase 3]
This update summarizes a Phase 2/Phase 3 study of StemEx for high-risk hematologic malignancies after myeloablative therapy, focusing on eff…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma [Phase 2]
Phase 2 study update for Rituximab-ABVD in classical Hodgkin lymphoma has completed recruitment with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial of MGCD0103 (MG-0103) for relapsed or refractory Hodgkin's lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial of MGCD0103 in combination with azacitidine (Vidaza) for relapsed or refractory Hodgkin lymphoma and non-Hodgkin lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and biological activity of oral clioquinol in patients with relapsed or refracto…
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy [Phase 1]
This Phase 1 clinical trial update reports the tolerance and biologic activity of oral ciclopirox olamine in patients with relapsed or refra…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Interleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 2]
Phase 2 trial update reporting completion of a study evaluating interleukin-12 in patients with various previously treated non-Hodgkin lymph…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma). [Phase 3]
Phase 3 open-label, single-arm trial evaluating safety and efficacy of Plerixafor with G-CSF for front-line mobilization in lymphoma and mul…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 2]
Phase 2 trial of SGN-30 (brentuximab vedotin) in combination with chemotherapy for relapsed or refractory Hodgkin lymphoma reported results.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Pilot Study of Unrelated Cord Blood Transplantation [Phase 2]
Phase 2 pilot trial of unrelated cord blood transplantation sponsored by King's College Hospital NHS Trust has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase 2 study of Galiximab for relapsed or refractory Hodgkin lymphoma has completed; results were posted in 2015.